[Immunotherapy use of keyhole-limpet hemocyanin in the treatment of bladder cancer. Preliminary study].
Jurincic
C D
CD
Engelman
U
U
Gasch
J
J
Klippel
K F
KF
D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006433:Hemocyanins / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007279:Injections, Subcutaneous / Q000379:methods; D008937:Mitomycins / Q000008:administration & dosage / Q000627:therapeutic use; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D011897:Random Allocation; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology
D007166:Immunosuppressive Agents; D008937:Mitomycins; D006433:Hemocyanins
Inmunoterapia con hemocianina Keyhole-Limpet en el cáncer de vejiga. Estudio aleatorio.